A potential anticancer agent 1,2-di(quinazolin-4-yl)diselane induces apoptosis in non-small-cell lung cancer A549 cells

[1]  Yinjiu Huang,et al.  To Preliminarily Evaluate The Anticancer Activiy of 1,2-di(quinazolin-4- yl)diselane Against MDA-MB-435 Cells in vitro , 2014 .

[2]  Yinjiu Huang,et al.  A potential anticancer agent 1,2-di(quinazolin-4-yl)diselane induces apoptosis in non-small-cell lung cancer A549 cells , 2014, Medicinal Chemistry Research.

[3]  X. Lei,et al.  Porcine serum can be biofortified with selenium to inhibit proliferation of three types of human cancer cells. , 2013, The Journal of nutrition.

[4]  Yu Cao,et al.  Preparation of Two Organoselenium Compounds and Their Induction of Apoptosis to SMMC-7221 Cells , 2013, Biological Trace Element Research.

[5]  L. Butler,et al.  Targeting cell cycle and hormone receptor pathways in cancer , 2013, Oncogene.

[6]  P. Witting,et al.  Selenium Metabolism in Cancer Cells: The Combined Application of XAS and XFM Techniques to the Problem of Selenium Speciation in Biological Systems , 2013, Nutrients.

[7]  D. Perrea,et al.  Terazosin Treatment Induces Caspase-3 Expression in the Rat Ventral Prostate , 2013, Journal of clinical medicine research.

[8]  Qinghua Zhou,et al.  Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer , 2013, PloS one.

[9]  Yu Cao,et al.  Preparation of a Novel Organoselenium Compound and Its Anticancer Effects on Cervical Cancer Cell Line HeLa , 2013, Biological Trace Element Research.

[10]  Kunihiko Kobayashi,et al.  Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC) , 2013, Targeted Oncology.

[11]  W. Rom,et al.  Chemoprevention of Lung Cancer: Prospects and Disappointments in Human Clinical Trials , 2013, Cancers.

[12]  M. Vinceti,et al.  Friend or Foe? The Current Epidemiologic Evidence on Selenium and Human Cancer Risk , 2013, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[13]  Ke-Wang Sun,et al.  Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway. , 2012, World journal of gastroenterology.

[14]  E. Reddy,et al.  CDK4: A Key Player in the Cell Cycle, Development, and Cancer. , 2012, Genes & cancer.

[15]  Ravi Radhakrishnan,et al.  Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain , 2012, The Biochemical journal.

[16]  S. Huh,et al.  Antiproliferative and Cytotoxic Effects of Resveratrol in Mitochondria-Mediated Apoptosis in Rat B103 Neuroblastoma Cells , 2012, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[17]  S. Katiyar,et al.  Bioactive Phytochemical Proanthocyanidins Inhibit Growth of Head and Neck Squamous Cell Carcinoma Cells by Targeting Multiple Signaling Molecules , 2012, PloS one.

[18]  Neha Singh,et al.  Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons , 2012, Molecular biology of the cell.

[19]  Jeffrey S. Hannam,et al.  Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer Cells , 2012, PloS one.

[20]  W. Slikker,et al.  Effects of copper nanoparticles on rat cerebral microvessel endothelial cells. , 2012, Nanomedicine.

[21]  B. Song,et al.  Antitumor effect of N-(4-chlorophenyl)-5,6,7- trimethoxyquinazolin-4-amine dihydrochloride on tumor cells in vitro , 2012 .

[22]  Yongzhi Yang,et al.  Cyclin D1 G870A Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Systematic Review of 22 Case-Control Studies , 2012, PloS one.

[23]  N. Lisiak,et al.  The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decrease , 2012, European journal of pharmacology.

[24]  S. Hariono,et al.  Kinetics of inhibitor cycling underlie therapeutic disparities between EGFR-driven lung and brain cancers. , 2012, Cancer discovery.

[25]  Li Zhao,et al.  Anti‐tumour activity of 4‐(4‐fluorophenyl)amino‐5,6,7‐trimethoxyquinazoline against tumour cells in vitro , 2012, Cell biology international.

[26]  C. Kim,et al.  CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib. , 2012, Journal of cancer research and therapeutics.

[27]  Wenjie Zheng,et al.  Surface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticles , 2012, International journal of nanomedicine.

[28]  S. Hill,et al.  Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer , 2012, PloS one.

[29]  Min Ji,et al.  Design, Synthesis, and In vitro Antitumor Activity Evaluation of Novel 4‐pyrrylamino Quinazoline Derivatives , 2011, Chemical biology & drug design.

[30]  S. Katiyar,et al.  Grape Proanthocyanidins Induce Apoptosis by Loss of Mitochondrial Membrane Potential of Human Non-Small Cell Lung Cancer Cells In Vitro and In Vivo , 2011, PloS one.

[31]  E. Aleknavičius,et al.  Targeted therapy in patients with non-small cell lung cancer previously treated with chemotherapy. , 2011, Medicina.

[32]  R. Radhakrishnan,et al.  A multiscale modeling approach to investigate molecular mechanisms of pseudokinase activation and drug resistance in the HER3/ErbB3 receptor tyrosine kinase signaling network. , 2011, Molecular bioSystems.

[33]  Xintian Zhang,et al.  An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells. , 2011, European journal of pharmacology.

[34]  M. Maayah,et al.  Evaluation of Transcutaneous Electrical Nerve Stimulation as a Treatment of Neck Pain due to Musculoskeletal Disorders , 2010, Journal of clinical medicine research.

[35]  T. Griffith,et al.  TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. , 2009, European journal of pharmacology.

[36]  J. M. Shields,et al.  Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  P. Herdewijn,et al.  Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf. , 2009, European journal of pharmacology.

[38]  Xianglin Shi,et al.  Induction of Apoptosis in Human Leukemia Cells by Grape Seed Extract Occurs via Activation of c-Jun NH2-Terminal Kinase , 2009, Clinical Cancer Research.

[39]  Y. Yatabe,et al.  Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations. , 2008, Cancer research.

[40]  J. Vadgama,et al.  Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells. , 2008, Anticancer research.

[41]  Steven P Gygi,et al.  Signaling networks assembled by oncogenic EGFR and c-Met , 2008, Proceedings of the National Academy of Sciences.

[42]  C. Ip,et al.  Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction. , 2007, Anticancer research.

[43]  Joon-Oh Park,et al.  MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling , 2007, Science.

[44]  Wancai Yang,et al.  JNK1 is required for sulindac-mediated inhibition of cell proliferation and induction of apoptosis in vitro and in vivo. , 2007, European journal of pharmacology.

[45]  M. Meyerson,et al.  EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. , 2005, The New England journal of medicine.

[46]  Martin L. Smith,et al.  Selenium compounds regulate p53 by common and distinctive mechanisms. , 2004, Anticancer research.

[47]  Y. Rustum,et al.  Selective Modulation of the Therapeutic Efficacy of Anticancer Drugs by Selenium Containing Compounds against Human Tumor Xenografts , 2004, Clinical Cancer Research.

[48]  Yinjiu Huang,et al.  Preliminary evaluation of the in vitro efficacy of 1, 2-di (quinazolin-4-yl) diselane against SiHa cervical cancer cells. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[49]  Jianping Chen,et al.  Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells. , 2012, Journal of pharmacological sciences.

[50]  S. Suman,et al.  An improved non-enzymatic “DNA ladder assay” for more sensitive and early detection of apoptosis , 2011, Cytotechnology.

[51]  G. Jin.  Pulchinenoside B4 inhibits proliferation and induces apoptosis of human liver cancer cell line HepG2 in vitro , 2011 .